121087418 | 121087441 | 1 | - | 27453484 | HT29 | resistance to T3SS1-dependent cytotoxicity | CTGAGTCCAACTTACCCCAAAGG | FCGR1B | ENSG00000198019 | 0.37785228207689436 | [2,2] | [1,3] | 7 | hSpCas9 | positive selection | 2988331 | 121087418 | 121087441 | 1 | - | 27453484 | HT29 | resistance to T3SS2-dependent cytotoxicity | CTGAGTCCAACTTACCCCAAAGG | FCGR1B | ENSG00000198019 | -0.527514591551076 | [2,2] | [1,0] | -7 | hSpCas9 | positive selection | 3056189 | 121087418 | 121087441 | 1 | - | 26780180 | HT29 | viability (Avana library 4 designs) | CTGAGTCCAACTTACCCCAAAGG | FCGR1B | ENSG00000198019 | 2.82439155389766 | [] | [] | 8 | hSpCas9 | negative selection | 3425236 | 121087418 | 121087441 | 1 | - | 26780180 | A375 | viability (Avana lentiCRISPRv2) | CTGAGTCCAACTTACCCCAAAGG | FCGR1B | ENSG00000198019 | -5.04722347448386 | [] | [] | -5 | hSpCas9 | negative selection | 3507265 | 121087418 | 121087441 | 1 | - | 26780180 | A375 | viability (Avana lentiGuide) | CTGAGTCCAACTTACCCCAAAGG | FCGR1B | ENSG00000198019 | 12.9327338793329 | [] | [] | 7 | hSpCas9 | negative selection | 3615924 | 121087418 | 121087441 | 1 | - | 26780180 | A375 | resistance to vemurafenib (Avana lentiCRISPRv2) | CTGAGTCCAACTTACCCCAAAGG | FCGR1B | ENSG00000198019 | -0.49510355811394124 | [4] | [3,1] | -6 | hSpCas9 | positive selection | 3724583 | 121087418 | 121087441 | 1 | - | 26780180 | A375 | resistance to vemurafenib (Avana lentiGuide) | CTGAGTCCAACTTACCCCAAAGG | FCGR1B | ENSG00000198019 | -1.4273915338688348 | [4] | [1,0] | -9 | hSpCas9 | positive selection | 3833190 | 121087423 | 121087446 | 1 | + | 27661255 | K562 | viability | GGGGTAAGTTGGACTCAGAGGGG | FCGR1B | ENSG00000198019 | 0.1274925604359295 | [960,1003] | [928,794] | 4 | dCas9-KRAB | negative selection | 5479922 |